DEUTSCHE BANK AG\ - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 46 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$7,000
+40.0%
14,976
+37.4%
0.00%
Q1 2015$5,000
-96.8%
10,900
-87.9%
0.00%
Q4 2014$155,000
+158.3%
90,232
+127.9%
0.00%
Q3 2014$60,000
-81.1%
39,596
-71.8%
0.00%
Q2 2014$318,000
-12.9%
140,281
+3.9%
0.00%
Q1 2014$365,000
-52.0%
135,006
-21.7%
0.00%
-100.0%
Q4 2013$760,000
-9.6%
172,379
-7.6%
0.00%0.0%
Q3 2013$841,000186,4930.00%
Other shareholders
KALOBIOS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Opus Point Partners Management, LLC 746,467$358,0000.28%
HARBOURVEST PARTNERS LLC 57,604$28,0000.01%
PRIMECAP MANAGEMENT CO/CA/ 4,327,600$2,077,0000.00%
Renaissance Technologies 564,673$271,0000.00%
VALLEY WEALTH MANAGERS, INC. 15,861$8,0000.00%
CITIGROUP INC 2,745$1,0000.00%
GOLDMAN SACHS GROUP INC 14,456$7,0000.00%
BLAIR WILLIAM & CO/IL 53,635$25,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 86,700$42,0000.00%
Tower Research Capital LLC (TRC) 3,055$1,0000.00%
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders